Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jing Ma, RenJi Hospital
ClinicalTrials.gov Identifier:
NCT02040246
First received: December 25, 2013
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)